Medical Center Hermes Ruse Ltd.
- Address
- Ulitsa Chavdar Voyvoda 12 Ground Floor, 7002 Rousse, Bulgaria
Respiratory Tract Diseases
The research at Medical Center Hermes Ruse Ltd. focuses on asthma and chronic obstructive pulmonary disease, testing new inhaled combinations and biologic agents to lower exacerbation rates and improve lung function.
- Asthma (mild to moderate, severe)
- Chronic Obstructive Pulmonary Disease (COPD)
- Triple bronchodilator therapy
- Biologic treatments such as tezepelumab and depemokimab
- Inhaled corticosteroid/long‑acting β2‑agonist combinations
Collaboration with global sponsors enables the site to evaluate innovative respiratory therapies, advancing care for patients across Europe.
Nutritional and Metabolic Diseases
A key study investigates colorectal cancer with cancer cachexia, assessing a novel compound designed to support body weight and metabolic health in affected patients.
- Colorectal cancer
- Cancer cachexia
- Weight management interventions
- Metabolic support therapies
- Patient‑reported quality‑of‑life outcomes
This work highlights Medical Center Hermes Ruse Ltd.'s dedication to addressing metabolic complications of cancer and improving patients’ overall well‑being.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1AstraZeneca AB3active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB3trials
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Medical Center Hermes Ruse Ltd.
lock Showing 1 of 10 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A 52-week, randomised, double blind, multicentre, 2-arm parallel group trial assessing the efficacy and safety of CHF6001 (total daily dose 3200 μg) Dry Powder Inhaler (DPI) add-on to maintenance medium or high dose inhaled corticosteroid in combination with long-acting ß2-agonists in subjects with uncontrolled asthma | Chiesi Farmaceutici S.p.A. | Phase II | Not Recruiting | Nov 2023 | Dec 2025 |
IMP list
lock Showing 1 of 11 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Formoterol Fumarate Dihydrate | 3 | Unknown | 2024-07-04 | 2026-04-13 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.